Haemonetics - 34 Year Stock Price History | HAE
Historical daily share price chart and data for Haemonetics since 1991 adjusted for splits and dividends. The latest closing stock price for Haemonetics as of June 12, 2025 is 71.36.
- The all-time high Haemonetics stock closing price was 139.48 on February 08, 2021.
- The Haemonetics 52-week high stock price is 94.98, which is 33.1% above the current share price.
- The Haemonetics 52-week low stock price is 55.30, which is 22.5% below the current share price.
- The average Haemonetics stock price for the last 52 weeks is 74.45.
| Haemonetics Historical Annual Stock Price Data | ||||||
|---|---|---|---|---|---|---|
| Year | Average Stock Price | Year Open | Year High | Year Low | Year Close | Annual % Change |
| 2025 | 66.6111 | 78.4000 | 80.0500 | 56.0400 | 71.3600 | -8.61% |
| 2024 | 81.9057 | 85.1400 | 97.3700 | 71.1600 | 78.0800 | -8.69% |
| 2023 | 85.3291 | 77.1800 | 93.4900 | 72.7500 | 85.5100 | 8.72% |
| 2022 | 66.5324 | 54.7000 | 86.1400 | 43.7700 | 78.6500 | 48.28% |
| 2021 | 79.1445 | 119.0700 | 139.4800 | 49.5500 | 53.0400 | -55.33% |
| 2020 | 101.0665 | 115.2700 | 121.8200 | 74.3400 | 118.7500 | 3.35% |
| 2019 | 109.5751 | 97.3000 | 138.5200 | 81.7400 | 114.9000 | 14.84% |
| 2018 | 90.5582 | 63.1000 | 116.6300 | 60.7200 | 100.0500 | 72.26% |
| 2017 | 43.6001 | 39.6000 | 58.9900 | 36.9000 | 58.0800 | 44.48% |
| 2016 | 33.6385 | 31.2500 | 41.0400 | 26.1300 | 40.2000 | 24.69% |
| 2015 | 38.4527 | 36.9200 | 45.3800 | 30.8500 | 32.2400 | -13.84% |
| 2014 | 35.9682 | 41.2800 | 43.3700 | 30.3600 | 37.4200 | -11.18% |
| 2013 | 41.3454 | 42.1300 | 45.8100 | 37.7500 | 42.1300 | 3.16% |
| 2012 | 36.4214 | 31.3900 | 41.3800 | 30.9250 | 40.8400 | 33.42% |
| 2011 | 31.0868 | 30.1400 | 35.1000 | 27.5050 | 30.6100 | -3.10% |
| 2010 | 28.1781 | 27.7150 | 32.1900 | 25.6200 | 31.5900 | 14.56% |
| 2009 | 27.4174 | 28.0050 | 32.3250 | 24.4250 | 27.5750 | -2.39% |
| 2008 | 28.8424 | 30.9200 | 32.7100 | 24.7950 | 28.2500 | -10.35% |
| 2007 | 25.2441 | 22.6900 | 31.5100 | 21.7500 | 31.5100 | 39.98% |
| 2006 | 24.0373 | 24.4000 | 27.4500 | 20.5450 | 22.5100 | -7.86% |
| 2005 | 21.6157 | 18.4000 | 26.3950 | 17.0800 | 24.4300 | 34.94% |
| 2004 | 15.1271 | 11.9700 | 18.4950 | 11.8700 | 18.1050 | 51.57% |
| 2003 | 10.5768 | 11.0000 | 12.2350 | 8.2400 | 11.9450 | 11.32% |
| 2002 | 13.6927 | 16.8400 | 17.1750 | 9.3500 | 10.7300 | -36.73% |
| 2001 | 16.3680 | 14.8438 | 20.8500 | 13.7000 | 16.9600 | 9.86% |
| 2000 | 11.9002 | 11.7813 | 15.4375 | 9.9375 | 15.4375 | 29.66% |
| 1999 | 9.4024 | 11.3438 | 12.0313 | 6.9063 | 11.9063 | 4.67% |
| 1998 | 8.7488 | 7.1563 | 11.4063 | 6.7500 | 11.3750 | 62.50% |
| 1997 | 8.5821 | 9.3750 | 10.5313 | 6.9063 | 7.0000 | -25.83% |
| 1996 | 9.1806 | 8.8750 | 10.8125 | 8.1875 | 9.4375 | 6.34% |
| 1995 | 9.0680 | 8.6250 | 11.5000 | 6.5625 | 8.8750 | 2.90% |
| 1994 | 9.6399 | 13.5000 | 13.6875 | 7.2500 | 8.6250 | -37.84% |
| 1993 | 11.7901 | 12.4688 | 14.1250 | 8.3750 | 13.8750 | 5.97% |
| 1992 | 8.4563 | 9.0938 | 13.0938 | 6.1875 | 13.0938 | 38.28% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $3.435B | $1.361B |
| Haemonetics Corp. provides blood management solutions to customers encompassing blood and plasma collectors, hospitals and health care providers globally. Its portfolio of integrated devices, information management, and consulting services offers blood management solutions for each facet of the blood supply chain, helping better clinical outcomes. It acquired Pall Corporation's blood collection, filtration and processing product lines. It entered into a long-term supply agreement with Pall. The company acquired Hemerus Medical. It operates under 3 segments: Plasma, Blood Center, and Hospital. Plasma includes plasma collection devices and disposables, plasma donor management software, anticoagulant and saline sold to plasma customers. Blood Center includes blood collection and processing devices and disposables for red cells, platelets and whole blood as well as related donor management software. Hospital includes three product lines, namely, Hemostasis Management, Cell Salvage and Transfusion Management. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $235.365B | 28.30 |
| Boston Scientific (BSX) | United States | $147.057B | 36.81 |
| Stryker (SYK) | United States | $145.454B | 30.41 |
| EssilorLuxottica (ESLOY) | France | $130.907B | 0.00 |
| Medtronic (MDT) | Ireland | $112.941B | 16.01 |
| Lonza Group Ag (LZAGY) | Switzerland | $50.659B | 0.00 |
| Haleon (HLN) | United Kingdom | $49.106B | 27.97 |
| ResMed (RMD) | United States | $36.856B | 27.68 |
| Agilent Technologies (A) | United States | $34.008B | 22.17 |
| GE HealthCare Technologies (GEHC) | United States | $33.609B | 15.96 |
| Terumo (TRUMY) | Japan | $26.946B | 35.00 |
| Koninklijke Philips (PHG) | Netherlands | $22.201B | 15.96 |
| Insulet (PODD) | United States | $21.270B | 83.49 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.645B | 11.98 |
| Baxter (BAX) | United States | $16.114B | 12.03 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $13.196B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $9.076B | 0.00 |
| Demant (WILYY) | Denmark | $8.854B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $6.264B | 21.80 |
| Lantheus Holdings (LNTH) | United States | $5.587B | 14.09 |
| Prestige Consumer Healthcare (PBH) | United States | $4.206B | 18.79 |
| Perrigo (PRGO) | Ireland | $3.763B | 9.54 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| ICU Medical (ICUI) | United States | $3.309B | 24.40 |
| Envista Holdings (NVST) | United States | $3.259B | 27.08 |
| GN Store Nord (GNNDY) | Denmark | $2.362B | 19.57 |
| QuidelOrtho (QDEL) | United States | $2.094B | 14.40 |
| LeMaitre Vascular (LMAT) | United States | $1.878B | 41.99 |
| AtriCure (ATRC) | United States | $1.635B | 0.00 |
| Acuren (TIC) | United States | $1.305B | 0.00 |
| Neogen (NEOG) | United States | $1.238B | 15.85 |
| AdaptHealth (AHCO) | United States | $1.181B | 11.99 |
| BioLife Solutions (BLFS) | United States | $1.128B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.075B | 24.19 |
| Kestra Medical Technologies (KMTS) | United States | $1.001B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.989B | 12.64 |
| InMode (INMD) | Israel | $0.903B | 9.10 |
| Evolus (EOLS) | United States | $0.660B | 0.00 |
| CeriBell (CBLL) | United States | $0.642B | 0.00 |
| Owens & Minor (OMI) | United States | $0.606B | 5.03 |
| Capricor Therapeutics (CAPR) | United States | $0.600B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.581B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.554B | 0.00 |
| Valneva SE (VALN) | France | $0.534B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.429B | 0.00 |
| Surmodics (SRDX) | United States | $0.415B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.359B | 13.21 |
| SNDL (SNDL) | Canada | $0.349B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.340B | 60.40 |
| Canopy Growth (CGC) | Canada | $0.289B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.283B | 0.00 |
| Cerus (CERS) | United States | $0.271B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.268B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.267B | 22.50 |
| ZimVie (ZIMV) | United States | $0.265B | 12.06 |
| Cresco Labs (CRLBF) | United States | $0.261B | 0.00 |
| Quanterix (QTRX) | United States | $0.259B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.257B | 0.00 |
| Brainsway (BWAY) | Israel | $0.222B | 58.65 |
| Biote (BTMD) | United States | $0.220B | 6.18 |
| OraSure Technologies (OSUR) | United States | $0.218B | 0.00 |
| Omeros (OMER) | United States | $0.212B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.199B | 0.00 |
| Organigram Global (OGI) | Canada | $0.197B | 0.00 |
| High Tide (HITI) | Canada | $0.190B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.185B | 15.09 |
| Verano Holdings (VRNOF) | United States | $0.183B | 0.00 |
| Exagen (XGN) | United States | $0.155B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.141B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.130B | 16.05 |
| Jin Medical (ZJYL) | China | $0.108B | 0.00 |
| MacroGenics (MGNX) | United States | $0.108B | 0.00 |
| Veru (VERU) | United States | $0.099B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.092B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.091B | 0.00 |
| Fonar (FONR) | United States | $0.090B | 11.61 |
| TerrAscend (TSNDF) | Canada | $0.078B | 0.00 |
| Agape ATP (ATPC) | $0.078B | 0.00 | |
| InterCure (INCR) | Israel | $0.071B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.068B | 0.00 |
| Apyx Medical (APYX) | United States | $0.067B | 0.00 |
| Zynex (ZYXI) | United States | $0.062B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.057B | 0.00 |
| ImmuCell (ICCC) | United States | $0.057B | 0.00 |
| Modular Medical (MODD) | United States | $0.047B | 0.00 |
| Nephros (NEPH) | United States | $0.040B | 54.21 |
| United-Guardian (UG) | United States | $0.038B | 13.18 |
| Rockwell Medical (RMTI) | United States | $0.034B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.020B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.020B | 0.00 |
| Safety Shot (SHOT) | United States | $0.019B | 0.00 |
| Flora Growth (FLGC) | United States | $0.018B | 0.00 |
| INLIF (INLF) | $0.014B | 0.00 | |
| Trinity Biotech (TRIB) | Ireland | $0.013B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.012B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.009B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.006B | 0.00 |
| Senestech (SNES) | United States | $0.005B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.005B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |